GE Medical
This article was originally published in The Gray Sheet
Executive Summary
Orders are being accepted for the GE CT-PET combination computed tomography and positron emission tomography diagnostic imaging device for cancerous tumors, following FDA clearance, announced April 13. Device combines technology from the GE LightSpeed QXi CT and GE Advance NXi PET scanner in a single platform